IPO registrations (S-1, F-1) · Registrants
MICRUS ENDOVASCULAR CORP
- SEC CIK
- 1028318 · filings on EDGAR ↗
- Former names
- MICRUS CORP (2002–2005)
- Registration
- Form S-1, first filed 2005-03-04, last 2005-06-14; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2005-06-16; declared effective 2006-07-13
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Business address
- 821 FOX LANE, San Jose, CA 95131
- EIN
- 23-2853441
- EDGAR entity type
- operating
- Insiders and CEO pay
- MICRUS ENDOVASCULAR CORP on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2005-06-14)
- Final price
- $11.00 per share, below the range (424B4 filed 2005-06-16, an initial public offering)
- Shares sold
- 3,250,000
- Gross proceeds
- $35,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MEND
- Lead underwriters
- A.G. Edwards
- Syndicate
- A.g. E Dwards; Needham & Company (1,180,000); Allen & Company (50,000); Dominick & Dominick LLC (50,000); Jefferies (50,000); KeyBanc Capital Markets, a Division of McDonald Investments Inc (50,000); Lazard (50,000); Montgomery & Co., LLC (50,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MICRUS ENDOVASCULAR CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Micrus Endovascular LLC Fuzzy (name and state)
- Business registration: MICRUS ENDOVASCULAR LLC Fuzzy (name and state)
- Form 5500 plan sponsor: MICRUS ENDOVASCULAR CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: MICRUS ENDOVASCULAR CORPORATION Fuzzy (name and state)
- SEC filer: MICRUS ENDOVASCULAR CORP EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-03-04 | S-1 | S-1 (registration) | MICRUS CORP | 0000891618-05-000197 ↗ |
| 2005-04-13 | S-1/A | S-1/A (amendment) | MICRUS CORP | 0000891618-05-000268 ↗ |
| 2005-05-06 | S-1/A | S-1/A (amendment) | MICRUS CORP | 0000891618-05-000334 ↗ |
| 2005-05-17 | S-1/A | S-1/A (amendment) | MICRUS CORP | 0000891618-05-000362 ↗ |
| 2005-05-23 | S-1/A | S-1/A (amendment) | MICRUS ENDOVASCULAR CORP | 0000950134-05-010623 ↗ |
| 2005-06-13 | S-1/A | S-1/A (amendment) | MICRUS ENDOVASCULAR CORP | 0000891618-05-000418 ↗ |
| 2005-06-14 | S-1/A | S-1/A (amendment) | MICRUS ENDOVASCULAR CORP | 0000950134-05-011922 ↗ |
| 2005-06-16 | 424B4 | 424B4 (final prospectus) | MICRUS ENDOVASCULAR CORP | 0000891618-05-000431 ↗ |
| 2006-07-13 | EFFECT | EFFECT (declared effective) | MICRUS ENDOVASCULAR CORP | 9999999995-06-000727 ↗ |
| 2006-07-14 | 424B4 | 424B4 (final prospectus) | MICRUS ENDOVASCULAR CORP | 0000950134-06-013195 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-06-14 | S-1/A | registration statement | $12.00–$14.00 | 3,250,000 | - | Nasdaq MEND | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 1, cover names 1 | document ↗ | |
| 2005-06-16 | 424B4 | final prospectus | $11.00 | 3,250,000 | $35,750,000 | Nasdaq MEND | 9 | primary document; price sentence, shares headline, proceeds table, underwriting table 7, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Colloton Robert C | Officer | Vice President; VP Global Sales & Marketing | 7 | 2006–2010 | |
| Stern Robert A | Officer | Executive Vice President, CFO; President, COO and Secretary; President, COO & Secretary | 9 | 2006–2010 | |
| Merz Beat | Director | 1 | 2006 | ||
| Holdych Tom M | Officer | Senior Vice President | 1 | 2006 | |
| Robbins Jim B | Officer | Vice President, Finance | 12 | 2006–2009 | |
| Ruppel Edward F Jr | Officer | SVP and Corp. Compliance Ofcr.; Vice President | 12 | 2006–2010 | |
| HENSON MICHAEL R | Director | 33 | 2006–2009 | ||
| HOLUBOW FRED | Director | 7 | 2006–2010 | ||
| Waddington Simon | Director | 1 | 2006 | ||
| Snyder Richard | Officer | VP, Human Resources | 7 | 2006–2010 | |
| Crompton R Michael | Officer | VP, Reg/Clinic. Affairs & Qual; VP Regulatory,Clinical&Quality | 6 | 2006–2010 | |
| EAGLE MICHAEL L | Director | 6 | 2006–2010 | ||
| Hopkins Leo Nelson | Director | 11 | 2006–2010 | ||
| Shammo Francis | Director | 5 | 2006–2010 | ||
| THIEL JEFFREY H | Director | 8 | 2006–2010 | ||
| WOLF GREGORY H | Director | 8 | 2006–2010 | ||
| Watson David A | Officer | Vice President R&D | 3 | 2006–2008 | |
| Bruguera Carolyn M | Officer | General Counsel; Vice Pres. & General Counsel | 6 | 2006–2010 | |
| Auran Mitch | Officer | Vice President | 5 | 2006–2008 | |
| HBM BIOVENTURES CAYMAN LTD | TenPercentOwner | 24 | 2007–2010 | ||
| Kilcoyne John T | Director,Officer | CEO and Chairman of the Board | 5 | 2007–2010 | |
| SANGSTER GORDON | Officer | Chief Financial Officer | 5 | 2007–2010 | |
| Rigas William G | Officer | Vice President of Sales | 2 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MICRUS ENDOVASCULAR CORPORATION | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | Micrus Endovascular LLC | CA | State business registries | name and state |
| Business registration | MICRUS ENDOVASCULAR LLC | CA | State business registries | name and state |
| Federal award recipient | MICRUS ENDOVASCULAR CORPORATION | CA | Federal spending (USAspending) | name and state |
| Patent assignee | Micrus Endovascular Corporation | CA | Patents (USPTO) | name and state |
| SEC filer | MICRUS ENDOVASCULAR CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Micrus Endovascular Corporation | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MICRUS ENDOVASCULAR CORPORATION | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- ENDOLOGIX INC /DE/ CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- AEROGEN INC CA
- IOMED LLC CA
- Adynxx, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology